Crohn’s disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis

References

• Rieder F, Fiocchi C, Rogler G. Mechanisms management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterol. 2017;152:e6.
   PubMed Web of Science ®Google Scholar
• Jeuring SF, van den Heuvel TR, Liu LY, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AAM, Jonkers DMAE, Pierik MJ. Improvements in the long-term outcome of Crohn’s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort. Am J Gastroenterol. 2017;112:325–19.
   PubMed Web of Science ®Google Scholar
• Ha CWY, Martin A, Sepich-Poore GD, Shi B, Wang Y, Gouin K, Humphrey G, Sanders K, Ratnayake Y, Chan KSL, et al. Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell. 2020;183(3):666–83 e17.
   PubMed Web of Science ®Google Scholar
• Caparros E, Wiest R, Scharl M, Rogler G, Gutierrez Casbas A, Yilmaz B, Wawrzyniak M, Francés R. Dysbiotic microbiota interactions in Crohn’s disease. Gut Microbes. 2021;13:1949096.
   PubMed Web of Science ®Google Scholar
• Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun. 2013;4:1957.
   PubMed Web of Science ®Google Scholar
• Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterol. 2008;134:768–780.
   PubMed Web of Science ®Google Scholar
• Imai J, Kitamoto S, Sugihara K, Nagao-Kitamoto H, Hayashi A, Morhardt TL, Kuffa P, Higgins PDR, Barnich N, Kamada N. Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis. Mucosal Immunol. 2019;12:632–643.
   PubMed Web of Science ®Google Scholar
• Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut. 2018;67:574–587.
   PubMed Web of Science ®Google Scholar
• Buisson A, Sokol H, Hammoudi N, Nancey S, Treton X, Nachury M, Fumery M, Hébuterne X, Rodrigues M, Hugot JP, et al. Role of adherent and invasive Escherichia coli in Crohn’s disease: lessons from the postoperative recurrence model. Gut. 2022;72(1):39–48.
   PubMed Web of Science ®Google Scholar
• Chokr D, Cornu M, Neut C, Bortolus C, Charlet R, Desreumaux P, Speca S, Sendid B. Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine. Gut Pathog. 2021;13:5.
   PubMed Web of Science ®Google Scholar
• Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531–543.
   PubMed Web of Science ®Google Scholar
• Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60:1090–1096.
   PubMed Web of Science ®Google Scholar
• Ren J, Li J, Feng Y, Shu B, Gui Y, Wei W, He W, Yang J, Dai C. Rictor/Mammalian target of rapamycin complex 2 promotes macrophage activation and kidney fibrosis. J Pathol. 2017;242:488–499.
   PubMed Web of Science ®Google Scholar
• Guo X, Li T, Xu Y, Xu X, Zhu Z, Zhang Y, Xu J, Xu K, Cheng H, Zhang X, et al. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice. J Biol Chem. 2017;292:14003–14015.
   PubMed Web of Science ®Google Scholar
• Johnson LA, Luke A, Sauder K, Moons DS, Horowitz JC, Higgins PD. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a “top-down” approach to intestinal fibrosis in mice. Inflamm Bowel Dis. 2012;18:460–471.
   PubMed Web of Science ®Google Scholar
• Salvador P, Macias-Ceja DC, Gisbert-Ferrandiz L, Hernandez C, Bernardo D, Alos R, Navarro-Vicente F, Esplugues JV, Ortiz-Masiá D, Barrachina MD, et al. CD16+ macrophages mediate fibrosis in inflammatory bowel disease. J Crohns Colitis. 2018;12(5):589–599.
   PubMed Web of Science ®Google Scholar
• Viladomiu M, Metz ML, Lima SF, Jin WB, Chou L, Bank JRILC, Guo CJ, Diehl GE, Simpson KW, Scherl EJ, et al. Adherent-invasive E. coli metabolism of propanediol in Crohn’s disease regulates phagocytes to drive intestinal inflammation. Cell Host & Microbe. 2021;29:607–19 e8.
   PubMed Web of Science ®Google Scholar
• Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, Satsangi J. MicroRNAs: new players in IBD. Gut. 2015;64(3):504–513.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Dalmasso G, Muller S, Carriere J, Seibold F, Darfeuille-Michaud A. Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRnas in intestinal epithelial cells to reduce autophagy. Gastroenterol. 2014;146:508–519.
   PubMed Web of Science ®Google Scholar
• Guo Z, Wu R, Gong J, Zhu W, Li Y, Wang Z, Li N, Li J. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn’s disease. J Gastroenterol Hepatol. 2015;30:109–116.
   PubMed Web of Science ®Google Scholar
• Gong L, Xiao J, Yi J, Xiao J, Lu F, Liu X. Immunomodulatory effect of serum exosomes from Crohn disease on macrophages via Let-7b-5p/tlr4 signaling. Inflamm Bowel Dis. 2022;28:96–108.
   PubMed Web of Science ®Google Scholar
• Guo Z, Cai X, Guo X, Xu Y, Gong J, Li Y, Zhu W. Let-7b ameliorates Crohn’s disease-associated adherent-invasive E coli induced intestinal inflammation via modulating toll-like receptor 4 expression in intestinal epithelial cells. Biochem Pharmacol. 2018;156:196–203.
   PubMed Web of Science ®Google Scholar
• Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, Zhao Y, Liu H, Fu X, Han W. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;13:308.
   PubMed Web of Science ®Google Scholar
• Wang B, Jha JC, Hagiwara S, McClelland AD, Jandeleit-Dahm K, Thomas MC, Cooper ME, Kantharidis P. Transforming growth factor-beta1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Kidney Int. 2014;85:352–361.
   PubMed Web of Science ®Google Scholar
• Cosin-Roger J, Ortiz-Masia D, Calatayud S, Hernandez C, Esplugues JV, Barrachina MD. The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD. Mucosal Immunol. 2016;9:986–998.
   PubMed Web of Science ®Google Scholar
• Piao S, Choi MJ, Tumurbaatar M, Kim WJ, Jin HR, Shin SH, Tuvshintur B, Yin GN, Song JS, Kwon MH, et al. Transforming growth factor (TGF)-beta type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-beta1 responses in fibroblasts derived from peyronie’s plaque. J Sex Med. 2010;7:3385–3395.
   PubMed Web of Science ®Google Scholar
• Massague J. Tgfbeta signalling in context. Nat Rev Mol Cell Biol. 2012;13:616–630.
   PubMed Web of Science ®Google Scholar
• Viladomiu M, Kivolowitz C, Abdulhamid A, Dogan B, Victorio D, Castellanos JG, Woo V, Teng F, Tran NL, Sczesnak A, et al. IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation. Sci Transl Med. 2017;9:eaaf9655.
   PubMed Web of Science ®Google Scholar
• Bringer MA, Billard E, Glasser AL, Colombel JF, Darfeuille-Michaud A. Replication of Crohn’s disease-associated AIEC within macrophages is dependent on TNF-alpha secretion. Lab Invest. 2012;92:411–419.
   PubMed Web of Science ®Google Scholar
• Bain CC, Mowat AM. Macrophages in intestinal homeostasis and inflammation. Immunol Rev. 2014;260:102–117.
   PubMed Web of Science ®Google Scholar
• Heinzmann D, Fuss S, Ungern-Sternberg SV, Schreieck J, Gawaz M, Gramlich M, Seizer P. Tgfbeta is specifically upregulated on circulating CD14++ CD16+ and CD14+ CD16++ monocytes in patients with atrial fibrillation and severe atrial fibrosis. Cell Physiol Biochem. 2018;49:226–234.
   PubMedGoogle Scholar
• Lescoat A, Lecureur V, Roussel M, Sunnaram BL, Ballerie A, Coiffier G, Jouneau S, Fardel O, Fest T, Jégo P. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis. Clin Rheumatol. 2017;36:1649–1654.
   PubMed Web of Science ®Google Scholar
• van den Bosch TP, Caliskan K, Kraaij MD, Constantinescu AA, Manintveld OC, Leenen PJ, von der Thüsen JH, Clahsen-van Groningen MC, Baan CC, Rowshani AT. CD16+ monocytes and skewed macrophage polarization toward M2 type hallmark heart transplant acute cellular rejection. Front Immunol. 2017;8:346.
   PubMed Web of Science ®Google Scholar
• Gren ST, Grip O. Role of monocytes and intestinal macrophages in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:1992–1998.
   PubMed Web of Science ®Google Scholar
• Scherberich JE, Nockher WA. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med. 1999;37:209–213.
   PubMed Web of Science ®Google Scholar
• Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. Let-7b is involved in the inflammation and immune responses associated with helicobacter pylori infection by targeting toll-like receptor 4. PLoS One. 2013;8:e56709.
   PubMed Web of Science ®Google Scholar
• Tang N, Wu Y, Cao W, Liang Y, Gao Y, Hu L, Yang, Q, Zhou, Y, Tang, F and Xiao, J, et al. Lentivirus-mediated over-expression of let-7b microRNA suppresses hepatic fibrosis in the mouse infected with schistosoma japonicum. Exp Parasitol. 2017;182:45–53.
   PubMed Web of Science ®Google Scholar
• Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res. 2011;157:191–199.
   PubMed Web of Science ®Google Scholar
• Gilles ME, Slack FJ. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy. Expert Opin Ther Targets. 2018;22:929–939.
   PubMed Web of Science ®Google Scholar
• Zhou LY, Qin Z, Zhu YH, He ZY, Xu T. Current RNA-based therapeutics in clinical trials. Curr Gene Ther. 2019;19:172–196.
   PubMed Web of Science ®Google Scholar
• Carriere J, Bretin A, Darfeuille-Michaud A, Barnich N, Nguyen HT. Exosomes released from cells infected with Crohn’s disease-associated adherent-invasive Escherichia coli activate host innate immune responses and enhance bacterial intracellular replication. Inflamm Bowel Dis. 2016;22:516–528.
   PubMed Web of Science ®Google Scholar
• Gomollon F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1. Diagn Med Manage J Crohns Colitis. 2017;11:3–25.
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterol. 2004;127:412–421.
   PubMed Web of Science ®Google Scholar
• Lopez-Siles M, Camprubi-Font C, Gomez Del Pulgar EM, Sabat Mir M, Busquets D, Sanz Y, Martinez-Medina M. Prevalence, abundance, and virulence of adherent-invasive Escherichia coli in ulcerative colitis, colorectal cancer, and coeliac disease. Front Immunol. 2022;13:748839.
   PubMed Web of Science ®Google Scholar